169 related articles for article (PubMed ID: 35866593)
1. Leptin stimulates migration and invasion and maintains cancer stem‑like properties in gastric cancer cells.
Park KB; Kim EY; Chin H; Yoon DJ; Jun KH
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866593
[TBL] [Abstract][Full Text] [Related]
2. The role of leptin in gastric cancer: clinicopathologic features and molecular mechanisms.
Lee KN; Choi HS; Yang SY; Park HK; Lee YY; Lee OY; Yoon BC; Hahm JS; Paik SS
Biochem Biophys Res Commun; 2014 Apr; 446(4):822-9. PubMed ID: 24569072
[TBL] [Abstract][Full Text] [Related]
3. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
Chen C; Chang YC; Lan MS; Breslin M
Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
[TBL] [Abstract][Full Text] [Related]
4. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
5. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
6. Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women.
Kato S; Abarzua-Catalan L; Trigo C; Delpiano A; Sanhueza C; García K; Ibañez C; Hormazábal K; Diaz D; Brañes J; Castellón E; Bravo E; Owen G; Cuello MA
Oncotarget; 2015 Aug; 6(25):21100-19. PubMed ID: 26053184
[TBL] [Abstract][Full Text] [Related]
7. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
8. Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.
Yan B; Liu L; Zhao Y; Xiu LJ; Sun DZ; Liu X; Lu Y; Shi J; Zhang YC; Li YJ; Wang XW; Zhou YQ; Feng SH; Lv C; Wei PK; Qin ZF
World J Gastroenterol; 2014 Sep; 20(36):13105-18. PubMed ID: 25278704
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
10. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
11. Leptin stimulates the epithelial‑mesenchymal transition and pro‑angiogenic capability of cholangiocarcinoma cells through the miR‑122/PKM2 axis.
Peng C; Sun Z; Li O; Guo C; Yi W; Tan Z; Jiang B
Int J Oncol; 2019 Jul; 55(1):298-308. PubMed ID: 31115511
[TBL] [Abstract][Full Text] [Related]
12. Novel Gastric Cancer Stem Cell-Related Marker LINGO2 Is Associated with Cancer Cell Phenotype and Patient Outcome.
Jo JH; Park SB; Park S; Lee HS; Kim C; Jung DE; Song SY
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696080
[TBL] [Abstract][Full Text] [Related]
13. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway.
Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW
Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840
[TBL] [Abstract][Full Text] [Related]
15. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma.
Zhu Y; Liu Y; Qian Y; Dai X; Yang L; Chen J; Guo S; Hisamitsu T
BMC Complement Altern Med; 2014 Nov; 14():433. PubMed ID: 25370696
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
[TBL] [Abstract][Full Text] [Related]
17. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.
Yang SW; Ping YF; Jiang YX; Luo X; Zhang X; Bian XW; Yu PW
Oncotarget; 2016 Jun; 7(26):39279-39292. PubMed ID: 27276686
[TBL] [Abstract][Full Text] [Related]
18. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
19. P-Akt/miR‑200 signaling regulates epithelial-mesenchymal transition, migration and invasion in circulating gastric tumor cells.
Yuan D; Xia H; Zhang Y; Chen L; Leng W; Chen T; Chen Q; Tang Q; Mo X; Liu M; Bi F
Int J Oncol; 2014 Dec; 45(6):2430-8. PubMed ID: 25200917
[TBL] [Abstract][Full Text] [Related]
20. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]